Navigation Links
'From the Web to human diseases,' UH talk uncovers network similarities
Date:10/2/2008

HOUSTON, Oct. 2, 2008 Comparing such diverse networks as the Internet and the human cell, Albert-Lszl Barabsi explains the mathematical foundation behind what he calls "the highly interconnected web of life." Barabsi will give a lecture titled "Network Science: From the Web to Human Diseases" at the University of Houston.

As part of the UH Tenneco Distinguished Lecture Series, Barabsi, Distinguished Professor and Director of Northeastern University's Center for Network Science, will be speaking at 5:30 p.m., Thursday, Oct. 9 in Room 232 of Philip Guthrie Hoffman Hall on the UH campus. The hour-long lecture is free and open to the public.

In his talk, he will address how the evolution of such complex, seemingly incongruous networks is united by similar complexities. Barabsi is known for using accessible language and concrete explanations laced with a special brand of humor.

"Recent studies indicate that the evolution of these complex networks is governed by simple but generic laws, resulting in apparently universal architectural features," Barabsi said. "I will discuss the amazing order characterizing our interconnected work, its implications on various phenomena from robustness to complex systems and its applications to communication and medicine."

Barabsi's seminal studies on complex networks demonstrated the existence of common characteristics in a wide range of disciplines, including chaos and fractals, materials science, biophysics and social networks. He has published five books, six major review articles and nearly 200 research publications. He is a member of the American Physical Society and was awarded the prestigious John von Neumann Medal from the Institute of Electrical and Electronics Engineers for his outstanding achievements in computer-related science and technology.

Inaugurated in 1986 and administered by the UH Center for Public History, the Tenneco Distinguished Lecture Series is
'/>"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
Source:Eurekalert

Page: 1 2

Related medicine news :

1. AUDIO from Medialink and UnitedHealthcare: Medicare Annual Enrollment Begins November 15th
2. MidSouth eHealth Alliance to Transition to Commercial Software Solution from Informatics Corporation of America
3. Jefferson awarded multi-million dollar grant from National Eye Institute for new clinical trial
4. ZocDoc Celebrates 1st Anniversary with Investments from Bezos, Benioff
5. Texas Health Resources Receives Grant From Robert Wood Johnson Foundation to Support Prevention of Family Violence
6. AxoGen Awarded Accreditation from American Association of Tissue Banks : Decision Affirms AxoGen's Commitment to Safety and Ethicality in the Development and Distribution of AVANCE Nerve Graft for Treatment of Peripheral Nerve Injuries
7. VIDEO from Medialink and Philips: Microbubbles Developed to Administer Medications That Fight Cancer and Reduce Side Effects
8. Herley New England Receives Additional $1.3 Million Contract Award from Lockheed Martin for the Multi-Mission Helicopter
9. A Statement from Lung Cancer Alliance on the Death of Paul Newman
10. Statement From Carroll Schroeder, Executive Director for the California Alliance of Child and Family Services, on Californias 2008-2009 Final Budget:
11. China-Biotics, Inc. Sees No Impact on Its Business From Dairy Products Safety Concerns

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)..., Higher Costs and Crushing Taxes Nail Nation...re-USNewswire/ -- In response to U.S. House passag...ess & Entrepreneurship Council (SBE Council) p...wing statement: ,, "Make no mistake, those vot... creators with higher costs and crushing taxes and...
(Date:11/8/2009)..., Freeze-drying of biopha...s Mississauga, Ontario facility. , ... Thomas Wellner, President and CEO of Therapure Bi...taken delivery of a commercial scale pharmaceutica...l scale freeze drying (lyophilization) available f...
(Date:11/8/2009)..., Nation,s largest network of Hispanic healt...th care reform in 2009 ,, WASHINGTON, Nov. 7 /...of Representatives showed they have heard the voic...Health Care for America Act. Now the Senate must d...l health care reform," said Dr. Jane L. Delgado, P...
(Date:11/8/2009)..., AARP Praises House Passage of Health Care ...engthen Medicare, improve coverage for all America...-- Today, the United States House of Representativ...re reform legislation that would strengthen Medica... companies that prices millions of Americans out o...
(Date:11/7/2009)..., WASHINGTON , Nov. 7 /PRNewswire-USNewswir...or today in support of H.R. 3962, the Affordable H...n the legislation later tonight. Below are the Sp...we all know, is an historic moment for our nation ...leaders of every party and political philosophy --...
Breaking Medicine News(10 mins):Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4
...give in to media pressure to give up cigarettes//....lammed critics who pick on her for smoking saying ...te Moss. Said Miller: "With me it's a terrib...e so cool. Why is that? I won't quit my fags." ...
... B.C. Roy Memorial Hospital here last week, laying...are facilities and bringing// back the horrors of ...te-run referral hospital for children. The 2... which are feared to have led to transfusion of HI...
...d clinical research to cure osteoarthritis without...inful condition to walk again, holding// out promi... Said to be the first of its kind in the world,... (Retd) V.G. Vasishta, former head of radio diagno...
...de in the liver from fatty foods that we eat. A ce...ood stream. Some cholesterol is needed to keep the... conditions such as angina, heart attack and strok... smoke, have high blood pressure are diabetic or o...
...ed woman lawyers not to wear veils in courtrooms, ... "You are professionals and should be dressed as ...Khan of the Peshawar High Court told veiled lawyer...rnment of proceedings in other lawyers' cases," sa...
...sed on November 3, 1906. One hundred years after i... on neuroscience, immunology and vaccine research ...develops and progresses. Researchers at the Yerkes... disorder. About 20 million Americans are currentl...
Other Medicine News:Health News:Crib deaths revisit Kolkata hospital, 22 infants die 2Health News:Indian radiologist spearheads cure for osteoarthritis sans surgery 2Health News:Indian radiologist spearheads cure for osteoarthritis sans surgery 3
(Date:11/6/2009)...-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nas...y, November 10, 2009 at 8:30 a.m. EST to discuss t...ss outlook for the remainder of 2009. Ron Bentsur...t the call. Keryx will announce its financial res...ed prior to the call. ,, In order to participat...
(Date:11/6/2009)...e/ -- NexBio Inc., in collaboration with scientist...n (CDC), St. Louis University, and the University ...wo articles in the peer-reviewed journal PLoS ONE....(Fludase ® ) may play a potentially important...emic Influenza A(H1N1) and drug-resistant influenz...
(Date:11/5/2009)...ewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OS...roducts for regenerative healing, today reported f...mber 30, 2009. ,, "During the third quarter of ...w biologic products MagniFuse(TM) Bone Graft, Fac...novative Grafting," said Sam Owusu-Akyaw, Presiden...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8PRA International to Host Audio Conference 55394 1PRA International to Host Audio Conference 55394 2Breakthroughs in Eye Care Products Offer Fresh Approach for Soothing Eyes 55389 1Breakthroughs in Eye Care Products Offer Fresh Approach for Soothing Eyes 55389 2Nuvilex Launches Last Shot Hangover Remedy 28TM 29 Web Site 55385 1Nuvilex Launches Last Shot Hangover Remedy 28TM 29 Web Site 55385 2Nuvilex Launches Last Shot Hangover Remedy 28TM 29 Web Site 55385 3Nuvilex Launches Last Shot Hangover Remedy 28TM 29 Web Site 55385 4
...atch, a publishing and,information services compan..., finds that investigative sites are required to l...s. More than 75% of respondents to a recent,Center...on three or more,EDC systems. In addition, a major...training had improved., State of the Clinical Tri...
...d soon after CEA Trial data reports in third quart...ISCO, May 15 VIA Pharmaceuticals,Inc. (Nasdaq: V...lopment of,compounds for the treatment of cardiova...ted patient enrollment in its acute coronary syndr...se 2 trials investigating VIA-2291,the company,s l...
Other Medicine Technology:CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5
Ident-A-Drug Reference 2005
...fic clinical trial activity and drug development u...rom CenterWatch. This highly valuable resource has... of medical breakthroughs on the frontiers of medi...ults, Newly Approved Drugs, Clinical Trials Listin...
Thomson CenterWatch Clinical Trial Listings
Drug Facts - Gold (A to Z Drugs and Drug Interaction)
Medicine Products: